Huntington's disease
| 3 min read
Promising new therapies for Huntington’s disease and multiple myeloma, the first FDA approval for Barth syndrome, and more led the news this week.
| 8 min read
A one-time gene therapy aims to stop Huntington's disease at its source. But first, it has to survive clinical trials.
Page 1 of 1 - 2 Total Items
